v3.26.3
Stockholder’s Deficit (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Equity [Abstract]    
Schedule of Reserved Shares of Common Stock for Future Issuance

The Company’s reserved shares of common stock for future issuance related to potential conversion of the Convertible Preferred Stock, exercise of Common Stock Warrants and exercise of stock options are as follows:

 

  

As of

June 30,

2026

  

As of

December 31,

2025

 
Common stock warrants   92,211    92,211 
Stock options   589,192    686,880 
SPAC public and private placement warrants (Refer note 16)   13,458,750    13,458,750 
Equity share warrant (Refer note 15)   2,108,070    2,108,070 
Issuance of warrants pursuant to conversion of convertible note (refer note 5)   30,000    30,000 
Restricted stock units (RSU) (Refer note 8)   1,217,210    - 
Reserved shares of common stock for future issuance   17,495,433    16,375,911 

The Company’s reserved shares of common stock for future issuance related to potential conversion of the Convertible Preferred Stock, exercise of Common Stock Warrants and exercise of stock options are as follows:

 

   As of December 31, 2025   As of December 31, 2024 
Convertible preferred stock (as converted to common stock)   -    5,950,673 
Common stock warrants   92,211    92,211 
Common stock contingent obligation   -    29,611 
Stock options   686,880    1,700,058 
Equity shares warrant (refer note 22)   2,108,070    -  
SPAC public and private placement warrants (refer note 24)   13,458,750    -  
Issuance of warrants pursuant to conversion of convertible note.(refer note 10)   30,000    - 
Reserved shares of common stock for future issuance   16,375,911    7,772,553 (1)

 

(1)Includes 6,772 stock options as of December 31, 2024 that were legally exercised prior to meeting the service base vesting requirements in exchange for nonrecourse promissory notes (Refer to “The Promissory Notes Transactions” in “Note 14 - Stock-based Compensation ”).